

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pseudouridine synthesis (GO:0001522) | 5.20356448 |
| 2 | proteasome assembly (GO:0043248) | 4.70133016 |
| 3 | DNA deamination (GO:0045006) | 4.41785184 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.20458011 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20458011 |
| 6 | NAD biosynthetic process (GO:0009435) | 4.04680458 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.78074661 |
| 8 | homocysteine metabolic process (GO:0050667) | 3.72501163 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71446649 |
| 10 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.70184337 |
| 11 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.70184337 |
| 12 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.68383576 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 3.64536257 |
| 14 | bone trabecula formation (GO:0060346) | 3.51468198 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45073816 |
| 16 | valine metabolic process (GO:0006573) | 3.38027149 |
| 17 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.36364605 |
| 18 | positive regulation of histone methylation (GO:0031062) | 3.33963778 |
| 19 | protein complex biogenesis (GO:0070271) | 3.32574879 |
| 20 | positive regulation of hair cycle (GO:0042635) | 3.27472114 |
| 21 | positive regulation of hair follicle development (GO:0051798) | 3.27472114 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.26669374 |
| 23 | DNA double-strand break processing (GO:0000729) | 3.25413724 |
| 24 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25036604 |
| 25 | response to interferon-beta (GO:0035456) | 3.25033816 |
| 26 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.23493143 |
| 27 | ribosomal small subunit assembly (GO:0000028) | 3.22489247 |
| 28 | complement activation, alternative pathway (GO:0006957) | 3.19413897 |
| 29 | tryptophan catabolic process (GO:0006569) | 3.16401254 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 3.16401254 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 3.16401254 |
| 32 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.13438968 |
| 33 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.11950052 |
| 34 | cellular response to interferon-beta (GO:0035458) | 3.11363600 |
| 35 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.10983278 |
| 36 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.10983278 |
| 37 | NADH dehydrogenase complex assembly (GO:0010257) | 3.10983278 |
| 38 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.10891702 |
| 39 | oligosaccharide catabolic process (GO:0009313) | 3.10259554 |
| 40 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.09364541 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 3.08771168 |
| 42 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.08195706 |
| 43 | fucose catabolic process (GO:0019317) | 3.06476105 |
| 44 | L-fucose metabolic process (GO:0042354) | 3.06476105 |
| 45 | L-fucose catabolic process (GO:0042355) | 3.06476105 |
| 46 | protein carboxylation (GO:0018214) | 3.04075110 |
| 47 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.04075110 |
| 48 | tryptophan metabolic process (GO:0006568) | 3.03627890 |
| 49 | kynurenine metabolic process (GO:0070189) | 3.01309508 |
| 50 | cell wall macromolecule catabolic process (GO:0016998) | 3.01105588 |
| 51 | low-density lipoprotein particle clearance (GO:0034383) | 3.00634926 |
| 52 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.99640658 |
| 53 | iron-sulfur cluster assembly (GO:0016226) | 2.98772986 |
| 54 | metallo-sulfur cluster assembly (GO:0031163) | 2.98772986 |
| 55 | regulation of protein activation cascade (GO:2000257) | 2.96655095 |
| 56 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.94424693 |
| 57 | purine nucleotide salvage (GO:0032261) | 2.93826155 |
| 58 | regulation of RIG-I signaling pathway (GO:0039535) | 2.93822381 |
| 59 | regulation of complement activation (GO:0030449) | 2.93240825 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.92651791 |
| 61 | L-phenylalanine metabolic process (GO:0006558) | 2.92651791 |
| 62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.91596643 |
| 63 | L-phenylalanine catabolic process (GO:0006559) | 2.91596643 |
| 64 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.90939132 |
| 65 | sulfur amino acid catabolic process (GO:0000098) | 2.90432010 |
| 66 | ATP synthesis coupled proton transport (GO:0015986) | 2.88900072 |
| 67 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.88900072 |
| 68 | regulation of sequestering of triglyceride (GO:0010889) | 2.87566447 |
| 69 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.87347227 |
| 70 | growth hormone receptor signaling pathway (GO:0060396) | 2.85532621 |
| 71 | response to water (GO:0009415) | 2.84850825 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.83898716 |
| 73 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.83710792 |
| 74 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.83710792 |
| 75 | cytochrome complex assembly (GO:0017004) | 2.83535916 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83035779 |
| 77 | base-excision repair, AP site formation (GO:0006285) | 2.82425794 |
| 78 | aldehyde catabolic process (GO:0046185) | 2.81841117 |
| 79 | actin nucleation (GO:0045010) | 2.81133760 |
| 80 | alpha-linolenic acid metabolic process (GO:0036109) | 2.80690149 |
| 81 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.78334218 |
| 82 | negative regulation of protein autophosphorylation (GO:0031953) | 2.77948044 |
| 83 | ribosomal large subunit biogenesis (GO:0042273) | 2.77555501 |
| 84 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.77466647 |
| 85 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.75293823 |
| 86 | cell wall macromolecule metabolic process (GO:0044036) | 2.72421060 |
| 87 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.71740491 |
| 88 | deoxyribose phosphate catabolic process (GO:0046386) | 2.71533993 |
| 89 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.69992723 |
| 90 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.69992723 |
| 91 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.69889553 |
| 92 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.69236617 |
| 93 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.68614419 |
| 94 | deoxyribonucleotide catabolic process (GO:0009264) | 2.67397063 |
| 95 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.65300479 |
| 96 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.64910838 |
| 97 | regulation of B cell differentiation (GO:0045577) | 2.63420020 |
| 98 | regulation of mitochondrial translation (GO:0070129) | 2.63280774 |
| 99 | response to lipoprotein particle (GO:0055094) | 2.63155678 |
| 100 | daunorubicin metabolic process (GO:0044597) | 2.63062476 |
| 101 | polyketide metabolic process (GO:0030638) | 2.63062476 |
| 102 | doxorubicin metabolic process (GO:0044598) | 2.63062476 |
| 103 | response to interferon-alpha (GO:0035455) | 2.61959351 |
| 104 | respiratory chain complex IV assembly (GO:0008535) | 2.61575583 |
| 105 | phospholipid efflux (GO:0033700) | 2.61301055 |
| 106 | response to parathyroid hormone (GO:0071107) | 2.60939455 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.60554332 |
| 108 | plasma lipoprotein particle clearance (GO:0034381) | 2.59104935 |
| 109 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.57425946 |
| 110 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.54252211 |
| 111 | electron transport chain (GO:0022900) | 2.53985302 |
| 112 | branched-chain amino acid catabolic process (GO:0009083) | 2.52902566 |
| 113 | amino-acid betaine metabolic process (GO:0006577) | 2.52716692 |
| 114 | cytidine deamination (GO:0009972) | 2.52541190 |
| 115 | cytidine metabolic process (GO:0046087) | 2.52541190 |
| 116 | cytidine catabolic process (GO:0006216) | 2.52541190 |
| 117 | response to type I interferon (GO:0034340) | 2.51273180 |
| 118 | positive regulation of granulocyte differentiation (GO:0030854) | 2.51062166 |
| 119 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.50556884 |
| 120 | reverse cholesterol transport (GO:0043691) | 2.50506309 |
| 121 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.50436262 |
| 122 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.49617561 |
| 123 | deoxyribose phosphate metabolic process (GO:0019692) | 2.49485464 |
| 124 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.49279807 |
| 125 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49052600 |
| 126 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.48603699 |
| 127 | phenylpropanoid metabolic process (GO:0009698) | 2.48434533 |
| 128 | complement activation (GO:0006956) | 2.48278255 |
| 129 | regulation of triglyceride catabolic process (GO:0010896) | 2.47731895 |
| 130 | oxidative phosphorylation (GO:0006119) | 2.47240514 |
| 131 | response to interleukin-15 (GO:0070672) | 2.46924998 |
| 132 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.46881981 |
| 133 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.46881981 |
| 134 | isotype switching (GO:0045190) | 2.46881981 |
| 135 | NAD metabolic process (GO:0019674) | 2.46564003 |
| 136 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.45804212 |
| 137 | cellular response to interleukin-15 (GO:0071350) | 2.45628898 |
| 138 | respiratory electron transport chain (GO:0022904) | 2.45532721 |
| 139 | negative regulation of lipid storage (GO:0010888) | 2.45403775 |
| 140 | type I interferon signaling pathway (GO:0060337) | 2.44704530 |
| 141 | cellular response to type I interferon (GO:0071357) | 2.44704530 |
| 142 | regulation of cholesterol storage (GO:0010885) | 2.43430515 |
| 143 | tRNA processing (GO:0008033) | 2.43224278 |
| 144 | DNA dealkylation (GO:0035510) | 2.42671020 |
| 145 | C-terminal protein lipidation (GO:0006501) | 2.42474088 |
| 146 | cysteine metabolic process (GO:0006534) | 2.42345169 |
| 147 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.42248480 |
| 148 | cellular response to vitamin (GO:0071295) | 2.42087113 |
| 149 | adenosine metabolic process (GO:0046085) | 2.41992069 |
| 150 | high-density lipoprotein particle remodeling (GO:0034375) | 2.41792176 |
| 151 | cellular response to vitamin D (GO:0071305) | 2.41006134 |
| 152 | negative regulation of granulocyte differentiation (GO:0030853) | 2.40848009 |
| 153 | lysine catabolic process (GO:0006554) | 2.40333674 |
| 154 | lysine metabolic process (GO:0006553) | 2.40333674 |
| 155 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.40272456 |
| 156 | cellular response to growth hormone stimulus (GO:0071378) | 2.39478088 |
| 157 | complement activation, classical pathway (GO:0006958) | 2.39470867 |
| 158 | mannosylation (GO:0097502) | 2.39093206 |
| 159 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.39087109 |
| 160 | aggressive behavior (GO:0002118) | 2.37819420 |
| 161 | negative regulation of fibrinolysis (GO:0051918) | 2.37370756 |
| 162 | purine-containing compound salvage (GO:0043101) | 2.37051412 |
| 163 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.36653471 |
| 164 | telomere maintenance via recombination (GO:0000722) | 2.36593835 |
| 165 | NIK/NF-kappaB signaling (GO:0038061) | 2.35770501 |
| 166 | nucleobase biosynthetic process (GO:0046112) | 2.35766554 |
| 167 | fatty acid beta-oxidation (GO:0006635) | 2.35211329 |
| 168 | protein activation cascade (GO:0072376) | 2.34466297 |
| 169 | regulation of humoral immune response (GO:0002920) | 2.34317887 |
| 170 | branched-chain amino acid metabolic process (GO:0009081) | 2.34296231 |
| 171 | mismatch repair (GO:0006298) | 2.34056179 |
| 172 | indolalkylamine metabolic process (GO:0006586) | 2.32148967 |
| 173 | urea metabolic process (GO:0019627) | 2.30762920 |
| 174 | urea cycle (GO:0000050) | 2.30762920 |
| 175 | acylglycerol homeostasis (GO:0055090) | 2.29754596 |
| 176 | triglyceride homeostasis (GO:0070328) | 2.29754596 |
| 177 | regulation of natural killer cell differentiation (GO:0032823) | 2.29442259 |
| 178 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.28731690 |
| 179 | fatty acid oxidation (GO:0019395) | 2.28498019 |
| 180 | triglyceride catabolic process (GO:0019433) | 2.28435948 |
| 181 | fibrinolysis (GO:0042730) | 2.28398885 |
| 182 | positive regulation of lipid catabolic process (GO:0050996) | 2.28291473 |
| 183 | lipid oxidation (GO:0034440) | 2.26381984 |
| 184 | diacylglycerol metabolic process (GO:0046339) | 2.25721493 |
| 185 | superoxide anion generation (GO:0042554) | 2.25518910 |
| 186 | positive regulation of interferon-alpha production (GO:0032727) | 2.23872888 |
| 187 | regulation of extracellular matrix disassembly (GO:0010715) | 2.23311260 |
| 188 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.23270687 |
| 189 | alkaloid metabolic process (GO:0009820) | 2.23068845 |
| 190 | bile acid biosynthetic process (GO:0006699) | 2.22873489 |
| 191 | acylglycerol catabolic process (GO:0046464) | 2.21602947 |
| 192 | neutral lipid catabolic process (GO:0046461) | 2.21602947 |
| 193 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.21364245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.03494923 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.84735097 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.77714976 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30158210 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.16979551 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.10018930 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.05524999 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.69099599 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.51042582 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.48958625 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.38620393 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.38220205 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.37728090 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.95132775 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.93386654 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68796036 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.59732834 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.59701499 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.57007746 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.52416160 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50565838 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.47462599 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46721967 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.44362236 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40712422 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.40310086 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29735688 |
| 28 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26872899 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.24768739 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.23193389 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.22910332 |
| 32 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.21690082 |
| 33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.15626629 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12066697 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.10738519 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.08651299 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07472368 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06926304 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04855088 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.02204960 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02147384 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00073087 |
| 43 | EWS_26573619_Chip-Seq_HEK293_Human | 1.99211774 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.95825904 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94322062 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92313161 |
| 47 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89065242 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87527652 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84138041 |
| 50 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.81625893 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80436900 |
| 52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79474074 |
| 53 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79253667 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77428254 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75674630 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75563559 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73006323 |
| 58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71957238 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70824188 |
| 60 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70481134 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63129698 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.61507715 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.60354666 |
| 64 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.60318917 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60203514 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58929336 |
| 67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.56046203 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55819396 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55364423 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53233128 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51741894 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51405725 |
| 73 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.50338159 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49552321 |
| 75 | MYB_26560356_Chip-Seq_TH2_Human | 1.48160875 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47663009 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46057126 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45689316 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45223923 |
| 80 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.44686314 |
| 81 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43460981 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.41086947 |
| 83 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39577557 |
| 84 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39252353 |
| 85 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.38051554 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35134401 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33895961 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32131407 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.28699278 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 1.27438433 |
| 91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25725239 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24614647 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22543247 |
| 94 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.22538689 |
| 95 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.22186173 |
| 96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18895015 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18895015 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16678834 |
| 99 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16428533 |
| 100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16223831 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.15981293 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.15981293 |
| 103 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15809566 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15197243 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13887700 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.13751280 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11518606 |
| 108 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10735013 |
| 109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10687597 |
| 110 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09464245 |
| 111 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09449836 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09415013 |
| 113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09406210 |
| 114 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09187906 |
| 115 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08980005 |
| 116 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08855886 |
| 117 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08204419 |
| 118 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.07892373 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06661490 |
| 120 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06463251 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04835604 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04599914 |
| 123 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04489198 |
| 124 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04383863 |
| 125 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03532658 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03314257 |
| 127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02792597 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02696722 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02544174 |
| 130 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01476417 |
| 131 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01476417 |
| 132 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99488649 |
| 133 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.98784857 |
| 134 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98402623 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97986839 |
| 136 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97825380 |
| 137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97141558 |
| 138 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97004039 |
| 139 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96596067 |
| 140 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95949244 |
| 141 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95054990 |
| 142 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94706656 |
| 143 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94176198 |
| 144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93127191 |
| 145 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93127191 |
| 146 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93112840 |
| 147 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92979208 |
| 148 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92723734 |
| 149 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.92709448 |
| 150 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92250202 |
| 151 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92186334 |
| 152 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92072991 |
| 153 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91334166 |
| 154 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91102007 |
| 155 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.90986849 |
| 156 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.90758016 |
| 157 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89410572 |
| 158 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88660628 |
| 159 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88550096 |
| 160 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88371393 |
| 161 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88335521 |
| 162 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88089354 |
| 163 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87751721 |
| 164 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87748650 |
| 165 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87375725 |
| 166 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87372670 |
| 167 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87204496 |
| 168 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87204496 |
| 169 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87033809 |
| 170 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.87004612 |
| 171 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81722572 |
| 172 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81412753 |
| 173 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.80191838 |
| 174 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79457292 |
| 175 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.78894307 |
| 176 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77082628 |
| 177 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77026346 |
| 178 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77022289 |
| 179 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77022289 |
| 180 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76598218 |
| 181 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76417904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.74690732 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.46999543 |
| 3 | MP0008058_abnormal_DNA_repair | 3.19998265 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.18414124 |
| 5 | MP0003195_calcinosis | 3.02668880 |
| 6 | MP0005360_urolithiasis | 2.98950944 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.68739682 |
| 8 | MP0004147_increased_porphyrin_level | 2.48129386 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.47068252 |
| 10 | MP0000685_abnormal_immune_system | 2.39693183 |
| 11 | MP0003724_increased_susceptibility_to | 2.35503287 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.33670899 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.28412987 |
| 14 | MP0003436_decreased_susceptibility_to | 2.26176360 |
| 15 | MP0008057_abnormal_DNA_replication | 2.23008361 |
| 16 | MP0001790_abnormal_immune_system | 2.22586190 |
| 17 | MP0005387_immune_system_phenotype | 2.22586190 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.22574889 |
| 19 | MP0005365_abnormal_bile_salt | 2.21404931 |
| 20 | MP0009785_altered_susceptibility_to | 2.20680195 |
| 21 | MP0001545_abnormal_hematopoietic_system | 2.04296776 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 2.04296776 |
| 23 | MP0003786_premature_aging | 2.01208158 |
| 24 | MP0005275_abnormal_skin_tensile | 2.01137953 |
| 25 | MP0009384_cardiac_valve_regurgitation | 1.98160363 |
| 26 | MP0003252_abnormal_bile_duct | 1.91959866 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.88079420 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.85100614 |
| 29 | MP0005670_abnormal_white_adipose | 1.77147197 |
| 30 | MP0001764_abnormal_homeostasis | 1.76327417 |
| 31 | MP0005083_abnormal_biliary_tract | 1.76043260 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.73600233 |
| 33 | MP0008995_early_reproductive_senescence | 1.72480095 |
| 34 | MP0001958_emphysema | 1.70213390 |
| 35 | MP0002419_abnormal_innate_immunity | 1.69405223 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.68907698 |
| 37 | MP0002132_abnormal_respiratory_system | 1.68621629 |
| 38 | MP0002254_reproductive_system_inflammat | 1.68029257 |
| 39 | MP0008872_abnormal_physiological_respon | 1.67743705 |
| 40 | MP0000516_abnormal_urinary_system | 1.67385807 |
| 41 | MP0005367_renal/urinary_system_phenotyp | 1.67385807 |
| 42 | MP0009764_decreased_sensitivity_to | 1.65132752 |
| 43 | MP0002933_joint_inflammation | 1.65107789 |
| 44 | MP0005671_abnormal_response_to | 1.64531869 |
| 45 | MP0005025_abnormal_response_to | 1.63696563 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.62509595 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.60402096 |
| 48 | MP0001800_abnormal_humoral_immune | 1.59629117 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.58648133 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.56165138 |
| 51 | MP0009840_abnormal_foam_cell | 1.55517466 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.54755540 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.54257708 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.54174375 |
| 55 | MP0001873_stomach_inflammation | 1.53602781 |
| 56 | MP0003718_maternal_effect | 1.51838161 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.49562604 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.47720905 |
| 59 | MP0002723_abnormal_immune_serum | 1.47573204 |
| 60 | MP0008469_abnormal_protein_level | 1.45679749 |
| 61 | MP0006082_CNS_inflammation | 1.44033162 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.43694732 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.43262975 |
| 64 | MP0005503_abnormal_tendon_morphology | 1.42997150 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 1.42645380 |
| 66 | MP0001853_heart_inflammation | 1.41790041 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.37334056 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.35253023 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.35164751 |
| 70 | MP0000609_abnormal_liver_physiology | 1.33426451 |
| 71 | MP0005332_abnormal_amino_acid | 1.31877746 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.28370761 |
| 73 | MP0002722_abnormal_immune_system | 1.27017287 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 1.26336732 |
| 75 | MP0002420_abnormal_adaptive_immunity | 1.26020427 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 1.25934216 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 1.25004322 |
| 78 | MP0001819_abnormal_immune_cell | 1.25002084 |
| 79 | MP0005464_abnormal_platelet_physiology | 1.24880465 |
| 80 | MP0004130_abnormal_muscle_cell | 1.24220812 |
| 81 | MP0005410_abnormal_fertilization | 1.24164039 |
| 82 | MP0002060_abnormal_skin_morphology | 1.23982580 |
| 83 | MP0002006_tumorigenesis | 1.21198223 |
| 84 | MP0002168_other_aberrant_phenotype | 1.19469028 |
| 85 | MP0002405_respiratory_system_inflammati | 1.18294659 |
| 86 | MP0001666_abnormal_nutrient_absorption | 1.17550628 |
| 87 | MP0003091_abnormal_cell_migration | 1.16480945 |
| 88 | MP0005636_abnormal_mineral_homeostasis | 1.15743724 |
| 89 | MP0003567_abnormal_fetal_cardiomyocyte | 1.15295588 |
| 90 | MP0002095_abnormal_skin_pigmentation | 1.14555434 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.14309134 |
| 92 | MP0009643_abnormal_urine_homeostasis | 1.14241514 |
| 93 | MP0003303_peritoneal_inflammation | 1.13787106 |
| 94 | MP0001542_abnormal_bone_strength | 1.13649886 |
| 95 | MP0002429_abnormal_blood_cell | 1.12102354 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 1.11582359 |
| 97 | MP0003186_abnormal_redox_activity | 1.11188063 |
| 98 | MP0002998_abnormal_bone_remodeling | 1.09876897 |
| 99 | MP0006054_spinal_hemorrhage | 1.08712274 |
| 100 | MP0002160_abnormal_reproductive_system | 1.07412297 |
| 101 | MP0004947_skin_inflammation | 1.06957742 |
| 102 | MP0005666_abnormal_adipose_tissue | 1.06292186 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 1.05478349 |
| 104 | MP0005023_abnormal_wound_healing | 1.03444803 |
| 105 | MP0003566_abnormal_cell_adhesion | 1.02585666 |
| 106 | MP0005379_endocrine/exocrine_gland_phen | 1.00883277 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 1.00191962 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.99931282 |
| 109 | MP0003279_aneurysm | 0.99831267 |
| 110 | MP0005165_increased_susceptibility_to | 0.99719847 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.99101488 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.98312297 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.97369287 |
| 114 | MP0004272_abnormal_basement_membrane | 0.96661921 |
| 115 | MP0002102_abnormal_ear_morphology | 0.96517436 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.96440274 |
| 117 | MP0000343_altered_response_to | 0.95868390 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.95330164 |
| 119 | MP0009763_increased_sensitivity_to | 0.94701433 |
| 120 | MP0003045_fibrosis | 0.94077394 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.93616081 |
| 122 | MP0005164_abnormal_response_to | 0.93277347 |
| 123 | MP0001661_extended_life_span | 0.91865723 |
| 124 | MP0008007_abnormal_cellular_replicative | 0.91817592 |
| 125 | MP0004883_abnormal_blood_vessel | 0.91586851 |
| 126 | MP0005389_reproductive_system_phenotype | 0.91070625 |
| 127 | MP0000716_abnormal_immune_system | 0.91038565 |
| 128 | MP0003075_altered_response_to | 0.90984561 |
| 129 | MP0002396_abnormal_hematopoietic_system | 0.90759947 |
| 130 | MP0003693_abnormal_embryo_hatching | 0.90036179 |
| 131 | MP0005390_skeleton_phenotype | 0.89839658 |
| 132 | MP0001905_abnormal_dopamine_level | 0.88629890 |
| 133 | MP0002876_abnormal_thyroid_physiology | 0.88385932 |
| 134 | MP0001929_abnormal_gametogenesis | 0.87736544 |
| 135 | MP0005253_abnormal_eye_physiology | 0.87595446 |
| 136 | MP0002971_abnormal_brown_adipose | 0.86054890 |
| 137 | MP0000858_altered_metastatic_potential | 0.85853887 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85728862 |
| 139 | MP0004510_myositis | 0.85606914 |
| 140 | MP0000490_abnormal_crypts_of | 0.84829479 |
| 141 | MP0000750_abnormal_muscle_regeneration | 0.84282922 |
| 142 | MP0004019_abnormal_vitamin_homeostasis | 0.83950336 |
| 143 | MP0000249_abnormal_blood_vessel | 0.83515360 |
| 144 | MP0009697_abnormal_copulation | 0.82435078 |
| 145 | MP0009278_abnormal_bone_marrow | 0.82426208 |
| 146 | MP0004808_abnormal_hematopoietic_stem | 0.82037736 |
| 147 | MP0000689_abnormal_spleen_morphology | 0.81362983 |
| 148 | MP0003763_abnormal_thymus_physiology | 0.80813636 |
| 149 | MP0005551_abnormal_eye_electrophysiolog | 0.80341431 |
| 150 | MP0002398_abnormal_bone_marrow | 0.79514708 |
| 151 | MP0005535_abnormal_body_temperature | 0.79045779 |
| 152 | MP0001119_abnormal_female_reproductive | 0.78488995 |
| 153 | MP0003806_abnormal_nucleotide_metabolis | 0.78355386 |
| 154 | MP0009046_muscle_twitch | 0.77315370 |
| 155 | MP0000653_abnormal_sex_gland | 0.75313880 |
| 156 | MP0008873_increased_physiological_sensi | 0.74748925 |
| 157 | MP0004957_abnormal_blastocyst_morpholog | 0.74644316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.55188068 |
| 2 | Congenital stationary night blindness (HP:0007642) | 3.50586061 |
| 3 | Myocardial infarction (HP:0001658) | 3.47620529 |
| 4 | Chromsome breakage (HP:0040012) | 3.42667165 |
| 5 | Myositis (HP:0100614) | 3.30923867 |
| 6 | Complement deficiency (HP:0004431) | 3.30546178 |
| 7 | Molar tooth sign on MRI (HP:0002419) | 3.28818395 |
| 8 | Abnormality of midbrain morphology (HP:0002418) | 3.28818395 |
| 9 | Bile duct proliferation (HP:0001408) | 3.26947072 |
| 10 | Abnormal biliary tract physiology (HP:0012439) | 3.26947072 |
| 11 | Severe combined immunodeficiency (HP:0004430) | 3.26938498 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21748613 |
| 13 | Xanthomatosis (HP:0000991) | 3.18036818 |
| 14 | Reticulocytopenia (HP:0001896) | 3.13616448 |
| 15 | Pancreatic cysts (HP:0001737) | 3.10726189 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.05003073 |
| 17 | Orchitis (HP:0100796) | 3.00426344 |
| 18 | Deep venous thrombosis (HP:0002625) | 2.99774052 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97789514 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.93656224 |
| 21 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.92550129 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 2.90058184 |
| 23 | Thyroiditis (HP:0100646) | 2.86677597 |
| 24 | Abnormality of the renal collecting system (HP:0004742) | 2.86160390 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 2.86012444 |
| 26 | Hypoproteinemia (HP:0003075) | 2.84229961 |
| 27 | True hermaphroditism (HP:0010459) | 2.83340193 |
| 28 | Mitochondrial inheritance (HP:0001427) | 2.82228016 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.80246638 |
| 30 | Abnormality of DNA repair (HP:0003254) | 2.76509901 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.76490092 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.76490092 |
| 33 | 3-Methylglutaconic aciduria (HP:0003535) | 2.76302752 |
| 34 | Duplicated collecting system (HP:0000081) | 2.75980011 |
| 35 | Hepatic necrosis (HP:0002605) | 2.75494540 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.75225013 |
| 37 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.75055849 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 2.73489620 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.72699877 |
| 40 | Acute encephalopathy (HP:0006846) | 2.72496094 |
| 41 | Severe visual impairment (HP:0001141) | 2.71764292 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70871949 |
| 43 | Pancreatic fibrosis (HP:0100732) | 2.69716494 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.68708044 |
| 45 | Split foot (HP:0001839) | 2.67230148 |
| 46 | Mesangial abnormality (HP:0001966) | 2.66529904 |
| 47 | Premature rupture of membranes (HP:0001788) | 2.66492298 |
| 48 | Type II lissencephaly (HP:0007260) | 2.66458534 |
| 49 | Increased CSF lactate (HP:0002490) | 2.66383263 |
| 50 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.66138691 |
| 51 | Hepatocellular necrosis (HP:0001404) | 2.64876856 |
| 52 | Clubbing of toes (HP:0100760) | 2.63217823 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.62993165 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.62628697 |
| 55 | Protrusio acetabuli (HP:0003179) | 2.61177149 |
| 56 | Abnormality of complement system (HP:0005339) | 2.60849045 |
| 57 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60602133 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58147070 |
| 59 | Joint hemorrhage (HP:0005261) | 2.57223786 |
| 60 | Combined immunodeficiency (HP:0005387) | 2.55755865 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.52798617 |
| 62 | Optic neuritis (HP:0100653) | 2.52798617 |
| 63 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.50785520 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.48677603 |
| 65 | Hydroxyprolinuria (HP:0003080) | 2.48677603 |
| 66 | Progressive macrocephaly (HP:0004481) | 2.47364258 |
| 67 | Meckel diverticulum (HP:0002245) | 2.47055764 |
| 68 | Pancreatitis (HP:0001733) | 2.46798733 |
| 69 | Abnormality of the preputium (HP:0100587) | 2.46793294 |
| 70 | Increased hepatocellular lipid droplets (HP:0006565) | 2.45267500 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.45231202 |
| 72 | Cerebral edema (HP:0002181) | 2.43830822 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.43412559 |
| 74 | Hyperlipoproteinemia (HP:0010980) | 2.43036209 |
| 75 | Hypoalphalipoproteinemia (HP:0003233) | 2.42354411 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.41542343 |
| 77 | Gingival bleeding (HP:0000225) | 2.41244886 |
| 78 | Renal cortical cysts (HP:0000803) | 2.40647304 |
| 79 | Abnormality of chromosome stability (HP:0003220) | 2.39265715 |
| 80 | Peritonitis (HP:0002586) | 2.38978412 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.36835746 |
| 82 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.35978785 |
| 83 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.35978785 |
| 84 | Hypertriglyceridemia (HP:0002155) | 2.35515640 |
| 85 | Oligodactyly (hands) (HP:0001180) | 2.35318488 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 2.33846282 |
| 87 | Abnormality of macrophages (HP:0004311) | 2.33739448 |
| 88 | Striae distensae (HP:0001065) | 2.31125577 |
| 89 | Recurrent abscess formation (HP:0002722) | 2.30469569 |
| 90 | Arterial thrombosis (HP:0004420) | 2.29871974 |
| 91 | Abnormality of the ileum (HP:0001549) | 2.29694569 |
| 92 | Amyloidosis (HP:0011034) | 2.29651626 |
| 93 | Broad metatarsal (HP:0001783) | 2.29647710 |
| 94 | Absent thumb (HP:0009777) | 2.28084949 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.27887285 |
| 96 | Nephronophthisis (HP:0000090) | 2.27400881 |
| 97 | Stomatitis (HP:0010280) | 2.26568161 |
| 98 | Hematochezia (HP:0002573) | 2.25984184 |
| 99 | Aplastic anemia (HP:0001915) | 2.25710674 |
| 100 | Tetraparesis (HP:0002273) | 2.24461963 |
| 101 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23708131 |
| 102 | Chronic otitis media (HP:0000389) | 2.21253674 |
| 103 | Abnormality of T cells (HP:0002843) | 2.21235467 |
| 104 | Neutropenia (HP:0001875) | 2.20245986 |
| 105 | Vertebral compression fractures (HP:0002953) | 2.20122835 |
| 106 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.19022446 |
| 107 | Alveolar cell carcinoma (HP:0006519) | 2.18758715 |
| 108 | Glomerulonephritis (HP:0000099) | 2.17131281 |
| 109 | Recurrent fungal infections (HP:0002841) | 2.17015421 |
| 110 | Petechiae (HP:0000967) | 2.16714234 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16257241 |
| 112 | IgG deficiency (HP:0004315) | 2.15130075 |
| 113 | Asplenia (HP:0001746) | 2.13682048 |
| 114 | B lymphocytopenia (HP:0010976) | 2.12826751 |
| 115 | Abnormality of B cell number (HP:0010975) | 2.12826751 |
| 116 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.12391419 |
| 117 | Ectopia lentis (HP:0001083) | 2.12140605 |
| 118 | Increased serum lactate (HP:0002151) | 2.11524278 |
| 119 | Nephritis (HP:0000123) | 2.10336836 |
| 120 | Basal ganglia calcification (HP:0002135) | 2.09964780 |
| 121 | Recurrent bacterial skin infections (HP:0005406) | 2.09283111 |
| 122 | Fat malabsorption (HP:0002630) | 2.08898895 |
| 123 | Abnormality of the prostate (HP:0008775) | 2.08698708 |
| 124 | Abolished electroretinogram (ERG) (HP:0000550) | 2.07717177 |
| 125 | Myelodysplasia (HP:0002863) | 2.05766162 |
| 126 | Pulmonary embolism (HP:0002204) | 2.05536656 |
| 127 | Increased muscle lipid content (HP:0009058) | 2.05046033 |
| 128 | Epidermoid cyst (HP:0200040) | 2.04302263 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 2.04259102 |
| 130 | Dicarboxylic aciduria (HP:0003215) | 2.02647282 |
| 131 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02647282 |
| 132 | Cardiovascular calcification (HP:0011915) | 2.01888902 |
| 133 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.01249932 |
| 134 | Polycythemia (HP:0001901) | 2.01058039 |
| 135 | Constricted visual fields (HP:0001133) | 2.00807296 |
| 136 | Meningitis (HP:0001287) | 2.00783136 |
| 137 | Panhypogammaglobulinemia (HP:0003139) | 1.99609793 |
| 138 | Autoimmune thrombocytopenia (HP:0001973) | 1.99356097 |
| 139 | Epistaxis (HP:0000421) | 1.98682496 |
| 140 | Vascular calcification (HP:0004934) | 1.98660597 |
| 141 | Hypoglycemic coma (HP:0001325) | 1.98064462 |
| 142 | Recurrent viral infections (HP:0004429) | 1.98057089 |
| 143 | Pancytopenia (HP:0001876) | 1.97879824 |
| 144 | Hypolipoproteinemia (HP:0010981) | 1.97820436 |
| 145 | Lactic acidosis (HP:0003128) | 1.97721953 |
| 146 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96945162 |
| 147 | Esophageal varix (HP:0002040) | 1.96670773 |
| 148 | Thrombophlebitis (HP:0004418) | 1.96395083 |
| 149 | Granulocytopenia (HP:0001913) | 1.94900551 |
| 150 | Type I transferrin isoform profile (HP:0003642) | 1.94872890 |
| 151 | Hypercholesterolemia (HP:0003124) | 1.94824113 |
| 152 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94769723 |
| 153 | Mucopolysacchariduria (HP:0008155) | 1.94769723 |
| 154 | Abnormality of purine metabolism (HP:0004352) | 1.93681061 |
| 155 | Menorrhagia (HP:0000132) | 1.93644409 |
| 156 | Mitral stenosis (HP:0001718) | 1.93400532 |
| 157 | Recurrent skin infections (HP:0001581) | 1.93068474 |
| 158 | Renal Fanconi syndrome (HP:0001994) | 1.92124636 |
| 159 | Aortic dissection (HP:0002647) | 1.91215520 |
| 160 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91142453 |
| 161 | Abnormal protein glycosylation (HP:0012346) | 1.91011721 |
| 162 | Abnormal glycosylation (HP:0012345) | 1.91011721 |
| 163 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.91011721 |
| 164 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.91011721 |
| 165 | Hyperalaninemia (HP:0003348) | 1.90759859 |
| 166 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90759859 |
| 167 | Abnormality of alanine metabolism (HP:0010916) | 1.90759859 |
| 168 | Vasculitis (HP:0002633) | 1.90522350 |
| 169 | Severe Myopia (HP:0011003) | 1.90449455 |
| 170 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90332595 |
| 171 | Eosinophilia (HP:0001880) | 1.90079824 |
| 172 | Generalized aminoaciduria (HP:0002909) | 1.89738802 |
| 173 | Duodenal stenosis (HP:0100867) | 1.89005815 |
| 174 | Small intestinal stenosis (HP:0012848) | 1.89005815 |
| 175 | Recurrent bronchitis (HP:0002837) | 1.87965012 |
| 176 | Attenuation of retinal blood vessels (HP:0007843) | 1.87392407 |
| 177 | Bifid tongue (HP:0010297) | 1.87060746 |
| 178 | Cervical subluxation (HP:0003308) | 1.86852351 |
| 179 | Steatorrhea (HP:0002570) | 1.86803743 |
| 180 | Abnormality of the renal cortex (HP:0011035) | 1.86510148 |
| 181 | T lymphocytopenia (HP:0005403) | 1.83963832 |
| 182 | Atrophic scars (HP:0001075) | 1.82777255 |
| 183 | Gastrointestinal inflammation (HP:0004386) | 1.82695342 |
| 184 | Skin nodule (HP:0200036) | 1.82656746 |
| 185 | Aortic aneurysm (HP:0004942) | 1.82602325 |
| 186 | Agammaglobulinemia (HP:0004432) | 1.81473846 |
| 187 | Prolonged bleeding time (HP:0003010) | 1.80306136 |
| 188 | Pendular nystagmus (HP:0012043) | 1.80061988 |
| 189 | Hyperammonemia (HP:0001987) | 1.78301807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.41399111 |
| 2 | SCYL2 | 3.01526918 |
| 3 | PIM2 | 2.87989552 |
| 4 | ADRBK2 | 2.86786358 |
| 5 | SIK1 | 2.75040030 |
| 6 | TBK1 | 2.71271607 |
| 7 | TGFBR2 | 2.56410757 |
| 8 | TRIB3 | 2.35678922 |
| 9 | JAK3 | 2.34861716 |
| 10 | VRK2 | 2.34286451 |
| 11 | MAP3K14 | 2.34139196 |
| 12 | MAP4K1 | 2.29510403 |
| 13 | IKBKE | 2.26582936 |
| 14 | CDK19 | 2.21970039 |
| 15 | FGFR4 | 2.20319037 |
| 16 | EIF2AK3 | 2.17858618 |
| 17 | ZAP70 | 2.17486946 |
| 18 | BLK | 2.09590991 |
| 19 | TYK2 | 2.02659880 |
| 20 | JAK1 | 2.00903920 |
| 21 | BCKDK | 2.00389233 |
| 22 | VRK1 | 1.97200885 |
| 23 | ZAK | 1.94993808 |
| 24 | MAP4K2 | 1.91094395 |
| 25 | FLT3 | 1.90618076 |
| 26 | MAP2K3 | 1.84424891 |
| 27 | STK16 | 1.79831451 |
| 28 | BMPR2 | 1.79609245 |
| 29 | OXSR1 | 1.78846231 |
| 30 | CSF1R | 1.78647805 |
| 31 | MAP3K3 | 1.77680866 |
| 32 | STK39 | 1.74251859 |
| 33 | MAP3K12 | 1.71656938 |
| 34 | KIT | 1.68928050 |
| 35 | NME2 | 1.64083370 |
| 36 | KDR | 1.61831801 |
| 37 | EIF2AK1 | 1.61180666 |
| 38 | IRAK1 | 1.59840076 |
| 39 | TESK2 | 1.56874347 |
| 40 | MST4 | 1.53435719 |
| 41 | IRAK3 | 1.52582168 |
| 42 | TAOK3 | 1.51013890 |
| 43 | BMPR1B | 1.50713361 |
| 44 | TLK1 | 1.47893455 |
| 45 | TNK2 | 1.45783313 |
| 46 | IKBKB | 1.41074249 |
| 47 | CSK | 1.40579470 |
| 48 | NLK | 1.39773322 |
| 49 | PKN2 | 1.39697486 |
| 50 | SRPK1 | 1.38745664 |
| 51 | EPHB1 | 1.36042658 |
| 52 | WNK4 | 1.35538834 |
| 53 | MAP3K11 | 1.32712875 |
| 54 | EPHA3 | 1.30369200 |
| 55 | IRAK4 | 1.27564492 |
| 56 | LRRK2 | 1.20271433 |
| 57 | BUB1 | 1.19561828 |
| 58 | RPS6KA4 | 1.19141036 |
| 59 | NEK9 | 1.19119333 |
| 60 | TEC | 1.15649402 |
| 61 | ERBB3 | 1.11005980 |
| 62 | MUSK | 1.10024576 |
| 63 | FRK | 1.09304284 |
| 64 | BTK | 1.08994472 |
| 65 | TAOK2 | 1.06310498 |
| 66 | CCNB1 | 1.05990390 |
| 67 | PLK4 | 1.04929591 |
| 68 | MST1R | 1.04749263 |
| 69 | EIF2AK2 | 1.04320713 |
| 70 | MAP3K13 | 1.02890842 |
| 71 | PTK6 | 1.01194574 |
| 72 | BMX | 1.00240867 |
| 73 | CDK8 | 0.95017772 |
| 74 | PBK | 0.91373759 |
| 75 | RIPK1 | 0.91005880 |
| 76 | PIK3CG | 0.90903298 |
| 77 | SIK3 | 0.90761996 |
| 78 | NEK1 | 0.89953346 |
| 79 | SYK | 0.89152159 |
| 80 | TXK | 0.87694630 |
| 81 | ARAF | 0.85935793 |
| 82 | LCK | 0.85862487 |
| 83 | TGFBR1 | 0.84333565 |
| 84 | CSNK1G3 | 0.82946078 |
| 85 | JAK2 | 0.82334785 |
| 86 | TTN | 0.82150395 |
| 87 | DAPK1 | 0.81941153 |
| 88 | ITK | 0.81931130 |
| 89 | CHUK | 0.81730335 |
| 90 | RPS6KB2 | 0.81355878 |
| 91 | SIK2 | 0.80134037 |
| 92 | MKNK1 | 0.78385594 |
| 93 | STK10 | 0.77311530 |
| 94 | TIE1 | 0.77114986 |
| 95 | MAPKAPK3 | 0.76735537 |
| 96 | PLK3 | 0.76279459 |
| 97 | CDK3 | 0.75593449 |
| 98 | FGFR3 | 0.74830597 |
| 99 | PIM1 | 0.74745042 |
| 100 | CDC7 | 0.73718772 |
| 101 | CAMK1D | 0.73643492 |
| 102 | ATR | 0.72881705 |
| 103 | TESK1 | 0.70794915 |
| 104 | TNIK | 0.70719160 |
| 105 | LYN | 0.69214457 |
| 106 | TRPM7 | 0.68126640 |
| 107 | INSRR | 0.67445611 |
| 108 | ADRBK1 | 0.67362136 |
| 109 | HCK | 0.65835712 |
| 110 | PTK2B | 0.65530345 |
| 111 | PDGFRB | 0.65429440 |
| 112 | FES | 0.65406000 |
| 113 | PRKCQ | 0.62339155 |
| 114 | WNK3 | 0.62031485 |
| 115 | RPS6KA5 | 0.61776455 |
| 116 | PRKAA2 | 0.60650996 |
| 117 | MAP3K10 | 0.60203361 |
| 118 | CSNK1G1 | 0.59659066 |
| 119 | PIK3CA | 0.58866026 |
| 120 | MAP3K1 | 0.57586821 |
| 121 | CSNK1G2 | 0.56424073 |
| 122 | CHEK2 | 0.55881619 |
| 123 | PTK2 | 0.55377173 |
| 124 | MAPKAPK5 | 0.55273517 |
| 125 | GRK1 | 0.54894861 |
| 126 | PRKCH | 0.52989867 |
| 127 | PRKG2 | 0.52802120 |
| 128 | CSNK1A1L | 0.52015973 |
| 129 | RAF1 | 0.51957557 |
| 130 | PLK1 | 0.51843877 |
| 131 | BRSK2 | 0.51059341 |
| 132 | FER | 0.50791357 |
| 133 | ATM | 0.50060424 |
| 134 | EGFR | 0.49891692 |
| 135 | IGF1R | 0.49744922 |
| 136 | MAPK11 | 0.48460176 |
| 137 | CAMKK2 | 0.48254333 |
| 138 | ABL1 | 0.48131635 |
| 139 | INSR | 0.47991351 |
| 140 | ABL2 | 0.47517833 |
| 141 | DYRK1B | 0.46865354 |
| 142 | CSNK2A2 | 0.46609726 |
| 143 | RPS6KB1 | 0.46462301 |
| 144 | PASK | 0.46144425 |
| 145 | NUAK1 | 0.45902844 |
| 146 | WEE1 | 0.45543939 |
| 147 | GRK6 | 0.44307105 |
| 148 | ACVR1B | 0.43347771 |
| 149 | MET | 0.43231257 |
| 150 | MAP2K6 | 0.42788400 |
| 151 | CSNK2A1 | 0.42514074 |
| 152 | RIPK4 | 0.41581486 |
| 153 | PDK2 | 0.41237190 |
| 154 | PRKCE | 0.39998852 |
| 155 | EPHA2 | 0.39964635 |
| 156 | MAPK13 | 0.39064835 |
| 157 | PHKG2 | 0.39057087 |
| 158 | MARK3 | 0.38402531 |
| 159 | MAPK15 | 0.38211347 |
| 160 | PRKCD | 0.37979555 |
| 161 | MOS | 0.37556481 |
| 162 | MAP3K7 | 0.37400597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 2.97930776 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.67801545 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.62495526 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.59532405 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.53559922 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52368632 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38633632 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.36549732 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.36074958 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33914433 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.29239392 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.28735691 |
| 13 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.26881298 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.26225968 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21217275 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13931740 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 2.11687933 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00896624 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.99455019 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.96417504 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.94171049 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.88382014 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86716156 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74733271 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.72695080 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.63844989 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63246151 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61940740 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.61281363 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61138741 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.59380406 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.56485669 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55706723 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55470902 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.54709597 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.53329570 |
| 37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.51385480 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51091979 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.45915906 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44416480 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41592442 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41265179 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40198750 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.38481731 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32660819 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29762544 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28416643 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.25738159 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23043861 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.22789047 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21288148 |
| 52 | Malaria_Homo sapiens_hsa05144 | 1.21157456 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20185339 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18365716 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17498984 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16821544 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 1.16545277 |
| 58 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15223750 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14555065 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14199879 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13487001 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13291548 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11272513 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10758060 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10222000 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08858000 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 1.08343353 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07670667 |
| 69 | Measles_Homo sapiens_hsa05162 | 1.07470150 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06547417 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.04513046 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.04271968 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02593114 |
| 74 | Spliceosome_Homo sapiens_hsa03040 | 1.02294647 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01334731 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 1.01331673 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01185787 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98278346 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.97370690 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96885281 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.96572903 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96383678 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95469533 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91794601 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.91404341 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90742044 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90109000 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.88711862 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88516480 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87900355 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87725156 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85887160 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85799992 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83806137 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82758057 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.81601151 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81539241 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80659685 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79382354 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78698632 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78363031 |
| 102 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77765936 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77423648 |
| 104 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76480767 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.73299788 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73177057 |
| 107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73003701 |
| 108 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69250392 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.69249562 |
| 110 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69235275 |
| 111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68329653 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67986229 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66697092 |
| 114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66656072 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65351685 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64803512 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64741837 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.64014546 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63552260 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61732445 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61449915 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.59205660 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58545425 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.57242421 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.56846849 |
| 126 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56788685 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.56570368 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56400880 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54599926 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54365584 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53359075 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.52808628 |
| 133 | Insulin resistance_Homo sapiens_hsa04931 | 0.51602702 |
| 134 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51100641 |
| 135 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50969712 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.50025888 |
| 137 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49953095 |
| 138 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49531714 |
| 139 | Protein export_Homo sapiens_hsa03060 | 0.47649858 |
| 140 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47133995 |
| 141 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44543394 |
| 142 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44407732 |
| 143 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44283752 |
| 144 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43555637 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.43119103 |
| 146 | Focal adhesion_Homo sapiens_hsa04510 | 0.43012435 |
| 147 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42925086 |
| 148 | Platelet activation_Homo sapiens_hsa04611 | 0.42888450 |
| 149 | Cell cycle_Homo sapiens_hsa04110 | 0.30047280 |

